Asma Latif

Suggest Changes
Learn More
BACKGROUND The approach of combining cytotoxic chemotherapy with oral small molecule tyrosine kinase inhibitors (TKIs) has been explored in a large number of randomized trials, in a variety of tumor.(More)
  • 1